Seminars & Events

Thursday, September 11, 2014: Dr. Bevil Conway (Wellesley College) will speak on his research in visual neuroscience and color at 4:30 pm in Goodpaster Hall 195.

Monday, October 27, 2014: Dr. Todd Gould (University of Maryland Baltimore) will speak on "Genes to behaviors to treatments in bipolar disorder" at 4:45 pm in Goodpaster Hall 195

Friday, December 5, 2014:  Dr. Brian Mathur (University of Maryland Baltimore) will speak on "Braking bad: Aberrant inhibitory neurotransmission in addiction" at 3:00 pm in Goodpaster Hall 195.

+ VIEW CALENDAR

Alumni Highlight

Check out Jordan Gaines Lewis '11's award-winning blog, Gaines on Brains. 

gainesonbrains.com

+ MORE

 

 

SMP Spotlight

Katie Gluskin and Jeff Haus present their SMP
Katie Gluskin and Jeff Haus, "Entorhinal Cortex Lesions, Habituation, and Latent Inhibition," 2013. Gluskin and Haus, the 2013 co-winners of the Neuroscience Award, infused a neurotoxin into the entorhinal cortex of rats to induce a lesion, and measured the resulting habituation and latent inhibition behavior within a fear conditioning paradigm.

+ MORE

Tracy, Megan (2011).  Investigating the efficacy of antipsychotic drug treatment on an animal model of schizophrenia. (Mentor: A. Bailey)

Abstract 

Schizophrenia is a disease that is difficult to study and understand due to its variety of symptoms and difficulty to fully treat. The most common treatment for the symptoms of schizophrenia is psychopharmaceutical therapy. Olanzapine is an atypical antipsychotic that is often prescribed for schizophrenia in adults and adolescents. Fifty-six long evans rats were used to test the effects of adolescent olanzapine administration in the NVHL animal model of schizophrenia. The animals’ play behavior was tested during adolescence while they were receiving either olanzapine or vehicle in their drinking water. In adulthood, the rats were tested for disrupted sensory gating and hyperlocomotion. The animals did not show significant differences in the prepulse inhibition task or the hyperlocomotion task. These results suggest that a different dose of olanzapine is necessary to see differences between the animal groups. There were significant differences seen during the adolescent play behavior, showing significantly increased play behavior in the control animals.